BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29958811)

  • 1. Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma.
    Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    HPB (Oxford); 2018 Dec; 20(12):1189-1197. PubMed ID: 29958811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.
    Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    Ann Surg Oncol; 2017 Sep; 24(9):2491-2501. PubMed ID: 28466403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.
    Yamamoto Y; Shimada K; Sakamoto Y; Esaki M; Nara S; Ban D; Kosuge T; Ojima H
    J Surg Oncol; 2009 Mar; 99(3):161-5. PubMed ID: 19101954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K; Yamamoto M; Ariizumi S
    Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    World J Surg; 2007 Oct; 31(10):2016-22. PubMed ID: 17687597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
    Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Rhee H; Kim MJ; Park YN; An C
    Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.
    Dover LL; Jacob R; Wang TN; Richardson JH; Redden DT; Li P; DuBay DA
    Am Surg; 2016 Nov; 82(11):1133-1139. PubMed ID: 28206944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass.
    Uno M; Shimada K; Yamamoto Y; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surg Today; 2012 Dec; 42(12):1189-94. PubMed ID: 22350300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma?
    Zhang XF; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Ann Surg Oncol; 2019 Jul; 26(7):2242-2250. PubMed ID: 30927194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
    Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
    J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
    Hu LS; Zhang XF; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Ann Surg Oncol; 2019 Aug; 26(8):2549-2557. PubMed ID: 31020501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
    Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A
    J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
    Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
    J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy.
    Yeh CN; Yeh TS; Chen TC; Jan YY; Chen MF
    J Gastroenterol; 2013 May; 48(5):647-59. PubMed ID: 23001251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.
    Shimada K; Sano T; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surgery; 2009 Apr; 145(4):411-6. PubMed ID: 19303990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma.
    Bagante F; Merath K; Squires MH; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    J Gastrointest Surg; 2018 Mar; 22(3):477-485. PubMed ID: 29352440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
    Zhang XF; Beal EW; Bagante F; Chakedis J; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Br J Surg; 2018 Jun; 105(7):848-856. PubMed ID: 29193010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.